Evidence map›Paper›PMID 41087449›Full record

ArticleScientific reports2025

Dosimetric and radiobiological benefits of patient-specific respiratory motion management for liver tumor stereotactic body radiotherapy.

Zhenhang Xu, Jiaxiang Gao, Te Xu, Haihua Lei, Qianhong Chen, Jiangshan Li, Miaoyun Huang, Xiaodong Wu, Yuangui Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhenhang Xu *Department of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Jiaxiang Gao *Department of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Te Xu *The School of Medical imaging, Fujian Medical University, Fuzhou, 350004, China.
Haihua LeiDepartment of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Qianhong ChenSchool Sino-US Program, Fuzhou No.8, Fuzhou, 350201, China.
Jiangshan LiDepartment of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Miaoyun HuangDepartment of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Xiaodong WuDepartment of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China. drxiaodongwu@yahoo.com.
Yuangui ChenDepartment of Radiation Oncology/Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors/Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fujian Medical University Union Hospital, Fuzhou, 350001, China. 2000cyg@fjmu.edu.cn.

Funding

Joint Funds for the Innovation of Science and Technology, Fujian Province 2023Y9136Natural Science Foundation of Fujian Province 2021J01740Subsidy Funds for the health, Fujian Provincial Department of Finance 2023CZ007
6 · The paper itself

Abstract

Respiratory motion management was crucial importance in radiotherapy. Our study aimed to explore the dosimetric and radiobiological benefits of various respiratory motion management strategies in liver tumor patients undergoing stereotactic body radiotherapy (SBRT). Respiratory motion images of 23 liver tumor patients were obtained by 4DCT scan under abdominal compression (AC) and free-breathing (FB). Group A included all 23 patients, while group B focused on 11 patients with tumors < 5 cm in diameter. Dosimetric and radiobiological parameters were recorded and compared across three treatment plans for each patient: Plan

Indexed as

Liver NeoplasmsRadiosurgeryRespirationAgedAged, 80 and overFemaleFour-Dimensional Computed TomographyHumansLiverMaleMiddle AgedRadiometryRadiotherapy DosageRadiotherapy Planning, Computer-Assisted4DCTDosimetryNTCPRespiratory motion management strategiesStereotactic body radiotherapy

Identifiers

PMID41087449
PMCPMC12521591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.